Press Releases
Exyte and Univercells Technologies combine forces for rapid deployment of vaccine production plants in the wake of the COVID-19 pandemic
Exyte, world-renowned for the design and construction of high tech facilities, and Univercells Technologies, a provider of novel biomanufacturing technologies for economic and scalable...
News
Demand for immunity products to be sustained long-term say SIRIO
SIRIO Europe (Ayanda) – the European headquarters of the SIRIO Group, a global nutraceutical contract development, innovation and manufacturing organization (CDiMO) – says considerable...
Packaging & Labelling
FedEx Delivers Relief Shipment to U.S. in fight against COVID-19
Amid the global COVID-19 pandemic, FedEx Express, a subsidiary of FedEx Corp. and the world’s largest express transportation company, has been working with nonprofit...
Press Releases
Virpax Pharmaceuticals Partners with MedPharm for Successful Completion of Pre-IND Meeting with FDA on Epoladerm
Virpax Pharmaceuticals Inc., a company specializing in developing pharmaceutical products for pain management by using new drug delivery systems, has announced that it had...
Clinical Trials
US pharma firm Gilead Sciences likely to seek nod to market anti-viral drug remdesivir in India
US pharmaceutical giant Gilead Sciences is likely to apply to India's Central Drugs Standard Control Organisation (CDSCO) soon seeking marketing authorisation for its anti-viral...
Press Releases
AstraZeneca advances response to global COVID-19 challenge as it receives first commitments for Oxford’s potential new vaccine
AstraZeneca is advancing its ongoing response to address the unprecedented challenges of COVID-19, collaborating with a number of countries and multilateral organisations to make...
Clinical Trials
Pfizer reports gene therapy data from Phase Ib DMD trial
Pfizer has reported new data from the Phase Ib clinical trial of PF-06939926 for the treatment of patients with Duchenne muscular dystrophy (DMD).
PF-06939926 is...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read